Mirae Asset Global ETFs Holdings
KNSA icon

Mirae Asset Global ETFs Holdings’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.24M Buy
+19,438
New +$1.01M ﹤0.01% 1521
2025
Q2 		– Sell
-22,843
Closed -$507K – 3128
2025
Q1 		$507K Buy
22,843
+1,002
+5% +$20.6K ﹤0.01% 1864
2024
Q4 		$432K Buy
21,841
+1,380
+7% +$31.5K ﹤0.01% 1995
2024
Q3 		$511K Buy
20,461
+4,191
+26% +$102K ﹤0.01% 1896
2024
Q2 		$304K Buy
+16,270
New +$305K ﹤0.01% 2064

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Mirae Asset Global ETFs Holdings's KNSA Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings opened a new position in Kiniksa Pharmaceuticals (KNSA) in Q2 2026: 19,438 shares worth $1.24M. The stake represents ﹤0.01% of the portfolio and ranks #1521 among its holdings. This is a return to the name: Mirae Asset Global ETFs Holdings previously reported a position in KNSA as recently as Q1 2025.

Mirae Asset Global ETFs Holdings first reported a position in KNSA in Q2 2024 and has held it in 5 quarters since. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 19,438 shares of Kiniksa Pharmaceuticals worth $1.24M as of Q2 2026.
  • Kiniksa Pharmaceuticals was a new Mirae Asset Global ETFs Holdings position in Q2 2026.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1521 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Kiniksa Pharmaceuticals in Q2 2024 and has held it in 5 quarters since.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.